Account
Ogilvy & Mather bags creative mandate for XRBIA Developers
MUMBAI: Housing brand XRBIA Developers has awarded its creative mandate to Ogilvy and Mather, beginning April 2015.
Promoted by Eiffel Group, XRBIA is headquartered in Pune with realty footprints spanning across Pune and Mumbai with over six million sq. ft. of existing development and 20 million sq. ft. of planned projects. The group’s spend is pegged at Rs 80 crore for the current financial year.
XRBIA Developers chairman and managing director Rahul Nahar said, “Constant innovation and creative thinking have been the cornerstones of our value offering and we found a perfect partner with Ogilvy & Mather as the extension of our creative team.”
Ogilvy & Mather CEO Kunal Jeswani added, “What excited me was the idea that they are bringing future ready homes to India. We are looking forward to this partnership.”
XRRBIA Developers CMO Pradeep Iyengar said, “We are delighted to partner with Ogilvy & Mather and are looking forward to the trademark creative differentiation that they can bring, which sits perfectly with what XRBIA is all about.”
XRBIA aims to provide sustainable housing solutions for every Indian and meet the need of infrastructural shortage by building 100 futuristic cities by 2030, out of which it has already announced the launch of 10 smart cities strategically located in value housing segment in the Mumbai-Pune corridor.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
